Cargando…

Therapeutic applications of CRISPR/Cas9 in breast cancer and delivery potential of gold nanomaterials

Globally, approximately 1 in 4 cancers in women are diagnosed as breast cancer (BC). Despite significant advances in the diagnosis and therapy BCs, many patients develop metastases or relapses. Hence, novel therapeutic strategies are required, that can selectively and efficiently kill malignant cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Padayachee, Jananee, Singh, Moganavelli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768851/
https://www.ncbi.nlm.nih.gov/pubmed/33488814
http://dx.doi.org/10.1177/1849543520983196